Brief Report - (2025) Volume 12, Issue 5
Received: 02-Oct-2025, Manuscript No. bset-26-181399;
Editor assigned: 05-Oct-2025, Pre QC No. P-181399;
Reviewed: 19-Oct-2025, QC No. Q-181399;
Revised: 23-Oct-2025, Manuscript No. R-181399;
Published:
30-Oct-2025
, DOI: 10.37421/2952-8526.2025.12.276
Citation: Herrera, Nicolas J. ”Soft Robotics: Revolutionizing Biomedical Innovation and Care.” J Biomed Syst Emerg Technol 12 (2025):276.
Copyright: © 2025 Herrera J. Nicolas This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Soft robotics is emerging as a transformative technology across various biomedical applications, driven by its inherent compliance and adaptability. The ability of soft robotic systems to interact safely with delicate biological tissues is opening unprecedented opportunities for minimally invasive surgical procedures. This advancement is significantly propelled by the development of novel materials and sophisticated control strategies, which collectively enable the creation of more intuitive and effective medical devices [1].
The domain of biomimetic soft actuators represents a critical area of research for the development of next-generation biomedical systems. These actuators, meticulously engineered to mimic the functionality of biological muscles, provide a high degree of dexterity and force generation capabilities. Such attributes are indispensable for sophisticated applications including robotic surgery and advanced rehabilitation devices. Innovations in material science and fabrication techniques are at the forefront of enhancing their performance and ensuring biocompatibility [2].
Soft robotic grippers are demonstrating substantial promise in the delicate task of tissue manipulation within biomedical contexts. Their unique capacity to conform to irregularly shaped biological structures and exert precise, gentle forces is paramount. This characteristic minimizes potential damage to organs and tissues during surgical interventions, thereby positioning them as ideal tools for handling fragile biological structures with enhanced safety and efficacy [3].
The integration of soft robotic technologies into minimally invasive surgery is currently a principal focus of ongoing development. Flexible and steerable soft robotic endoscopes and surgical instruments are engineered to navigate complex anatomical pathways with superior ease and reduced patient trauma compared to their rigid counterparts. This enhanced navigability significantly improves patient outcomes and broadens the scope of possibilities for endoscopic procedures [4].
Wearable soft robotic systems are rapidly emerging as powerful and versatile tools for both rehabilitation and assistive applications. These systems, frequently designed in the form of soft exosuits, offer tailored mechanical support and therapeutic assistance to individuals experiencing mobility impairments. Their application promotes functional recovery and fosters greater independence in daily activities [5].
Drug delivery systems are undergoing significant enhancements through the application of soft robotic principles, enabling more targeted and precisely controlled release of therapeutic agents. Micro-scale soft robots, for instance, are capable of navigating the intricate pathways of the bloodstream or other bodily fluids to deliver medications directly to affected areas. This targeted approach minimizes systemic side effects and substantially improves overall treatment efficacy [6].
The development of sophisticated soft sensors and integrated sensing capabilities is fundamentally vital for the creation of intelligent soft robotic systems designed for biomedical applications. These advanced sensors are capable of accurately monitoring forces, pressures, and strains during critical interactions with biological tissues. This provides essential real-time feedback necessary for precise control and ensures operational safety [7].
Soft robotic endoscopes are being meticulously engineered to offer enhanced maneuverability and advanced imaging capabilities for both internal diagnostics and therapeutic interventions. Their inherent flexibility allows for significantly safer navigation through narrow and tortuous anatomical paths within the human body. This capability holds the potential to facilitate earlier and more accurate diagnoses, leading to improved patient care pathways [8].
The critical importance of bio-compatibility and biodegradability of materials employed in soft robotics cannot be overstated, particularly for applications involving implants and internal biomedical devices. Ongoing research into novel hydrogels and advanced polymers is paving the way for the creation of soft robotic components that can safely reside within the body and eventually degrade without eliciting adverse physiological effects, ensuring patient safety and well-being [9].
Effective control strategies for soft robotic systems deployed in complex biomedical settings necessitate the development of advanced algorithms. These algorithms must meticulously account for the inherent flexibility and non-linear dynamics characteristic of soft robots. Developing robust and adaptive control methodologies is paramount to achieving the precise movements and safe interactions required within intricate biological environments [10].
Soft robotics, characterized by its inherent compliance and adaptability, is ushering in a new era of innovation within biomedical systems. The unique capacity of these robots to engage safely with delicate biological tissues is creating novel avenues for advancements in minimally invasive surgical techniques. Furthermore, their application extends to precise targeted drug delivery mechanisms and the development of highly sophisticated prosthetic devices. This significant progress is underpinned by ongoing research into novel materials and the implementation of advanced control strategies, ultimately facilitating the creation of more intuitive and effective medical devices [1].
The advancement of biomimetic soft actuators is paramount for the realization of next-generation biomedical systems. These actuators, designed to emulate the functional capabilities of biological muscles, offer remarkable dexterity and force generation potential, which are essential for critical applications such as robotic surgery and comprehensive rehabilitation devices. Continuous innovation in material science and fabrication methodologies is crucial for enhancing their performance metrics and ensuring their biocompatibility for safe use within the human body [2].
Soft robotic grippers are exhibiting considerable potential for applications involving the delicate manipulation of biological tissues in medical settings. Their exceptional ability to conform to irregular anatomical shapes and exert controlled, gentle forces is vital for minimizing trauma to vital organs and tissues during surgical procedures. This makes them particularly well-suited for handling fragile biological structures with a high degree of precision and safety [3].
The integration of soft robotic systems into the field of minimally invasive surgery is a focal point of current research and development. The inherent flexibility and steerability of soft robotic endoscopes and surgical instruments enable them to navigate complex internal anatomical pathways more readily and with reduced patient trauma compared to conventional rigid instruments. This enhancement contributes to improved patient outcomes and expands the diagnostic and therapeutic possibilities of endoscopic interventions [4].
Emerging wearable soft robotic systems are proving to be invaluable tools for individuals requiring rehabilitation and assistive support. These systems, often designed as flexible exosuits, provide customized mechanical support and therapeutic assistance to individuals with compromised mobility. Their use promotes functional recovery, enhances independence, and improves the quality of life for those with physical impairments [5].
Soft robotic principles are being applied to enhance drug delivery systems, enabling more precise and controlled administration of therapeutic agents. Micro-scale soft robots possess the capability to navigate complex biological environments, such as the bloodstream, to deliver drugs directly to specific sites of action. This targeted delivery approach is crucial for minimizing unwanted systemic side effects and maximizing the therapeutic efficacy of treatments [6].
The development of advanced soft sensors and integrated sensing capabilities is fundamental to the creation of intelligent soft robotic systems for biomedical applications. These sensors are designed to accurately monitor physical parameters like forces, pressures, and strains during interaction with biological tissues. The real-time data they provide is essential for sophisticated control systems and ensures the safe operation of these robots in sensitive environments [7].
Soft robotic endoscopes are being meticulously engineered to offer superior maneuverability and advanced imaging capabilities for both internal diagnostic procedures and interventional treatments. Their inherent flexibility facilitates safer navigation through intricate and often narrow anatomical passages within the body. This improved access and visualization can lead to earlier detection and more accurate diagnoses, ultimately benefiting patient care [8].
The bio-compatibility and biodegradability of materials used in the fabrication of soft robots for biomedical purposes are of utmost importance, especially for applications involving internal implants and devices. Active research into novel hydrogels and biocompatible polymers is enabling the creation of soft robotic components that can be safely introduced into the body and subsequently degrade over time without causing harm or adverse reactions, ensuring long-term patient safety [9].
Implementing effective control strategies for soft robotic systems operating within the demanding domain of biomedical applications requires the development of sophisticated algorithms. These algorithms must be capable of managing the inherent flexibility and complex non-linear behaviors of soft robots. The creation of robust and adaptive control mechanisms is therefore critical for achieving the high levels of precision and safety necessary for interaction within biological environments [10].
Soft robotics is revolutionizing biomedical applications through its inherent compliance and adaptability, enabling safer interaction with delicate tissues for minimally invasive surgery, targeted drug delivery, and advanced prosthetics. Key developments include biomimetic soft actuators inspired by biological muscles, offering dexterity for robotic surgery and rehabilitation. Soft robotic grippers excel at delicate tissue manipulation, minimizing damage during procedures. In minimally invasive surgery, flexible soft robotic endoscopes enhance navigation and reduce trauma. Wearable soft robotic exosuits provide crucial support for rehabilitation and assistance. Micro-scale soft robots are being developed for targeted drug delivery, improving efficacy and reducing side effects. Advanced soft sensors are vital for intelligent control and safe interaction. Bio-compatible and biodegradable materials are critical for internal devices. Robust control strategies are essential for precise and safe operation in complex biological environments.
None
None
